CEF chemotherapy for advanced gastro-oesophageal cancer

被引：0
|
作者：
Lacko, A
Woll, PJ
Langley, RE
Thomas, A
Carmichael, J
机构：
[1] WROCLAW UNIV MED,DEPT ONCOL,PL-53413 WROCLAW,POLAND
[2] CITY HOSP,CRC,DEPT CLIN ONCOL,NOTTINGHAM NG5 1PB,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1272 / 1272
页数：1
相关论文
共 50 条
  • [1] Chemotherapy with nivolumab in advanced gastro-oesophageal adenocarcinoma
    Fong, Caroline
    Cunningham, David
    [J]. LANCET, 2021, 398 (10294): : 2 - 3
  • [2] Perioperative chemotherapy for gastro-oesophageal cancer
    Taylor, Rosie
    [J]. LANCET ONCOLOGY, 2006, 7 (08): : 624 - 624
  • [3] Lapatinib with chemotherapy for gastro-oesophageal cancer
    Stirrups, Robert
    [J]. LANCET ONCOLOGY, 2019, 20 (08): : E400 - E400
  • [4] Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
    Shitara, Kohei
    Ajani, Jaffer A.
    Moehler, Markus
    Garrido, Marcelo
    Gallardo, Carlos
    Shen, Lin
    Yamaguchi, Kensei
    Wyrwicz, Lucjan
    Skoczylas, Tomasz
    Bragagnoli, Arinilda Campos
    Liu, Tianshu
    Tehfe, Mustapha
    Elimova, Elena
    Bruges, Ricardo
    Zander, Thomas
    de Azevedo, Sergio
    Kowalyszyn, Ruben
    Pazo-Cid, Roberto
    Schenker, Michael
    Cleary, James M.
    Yanez, Patricio
    Feeney, Kynan
    Karamouzis, Michalis, V
    Poulart, Valerie
    Lei, Ming
    Xiao, Hong
    Kondo, Kaoru
    Li, Mingshun
    Janjigian, Yelena Y.
    [J]. NATURE, 2022, 603 (7903) : 942 - +
  • [5] Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
    Kohei Shitara
    Jaffer A. Ajani
    Markus Moehler
    Marcelo Garrido
    Carlos Gallardo
    Lin Shen
    Kensei Yamaguchi
    Lucjan Wyrwicz
    Tomasz Skoczylas
    Arinilda Campos Bragagnoli
    Tianshu Liu
    Mustapha Tehfe
    Elena Elimova
    Ricardo Bruges
    Thomas Zander
    Sergio de Azevedo
    Ruben Kowalyszyn
    Roberto Pazo-Cid
    Michael Schenker
    James M. Cleary
    Patricio Yanez
    Kynan Feeney
    Michalis V. Karamouzis
    Valerie Poulart
    Ming Lei
    Hong Xiao
    Kaoru Kondo
    Mingshun Li
    Yelena Y. Janjigian
    [J]. Nature, 2022, 603 : 942 - 948
  • [6] Neoadjuvant chemotherapy in "technically" inoperable locally advanced oesophageal (0) and gastro-oesophageal junction (GOJ) cancer
    Cheong, KA
    Chrystal, K
    Forshaw, M
    Gossage, J
    Galani, E
    Botha, A
    Mason, R
    Harper, PG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 347S - 347S
  • [7] Gastro-oesophageal cancer in Scotland
    Park, KGM
    [J]. GUT, 2002, 50 : A110 - A110
  • [8] Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
    Young, Kate
    Smyth, Elizabeth
    Chau, Ian
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (06): : 373 - 383
  • [9] IMPACT OF MODEL APPROACH ON ECONOMIC EVALUATION OF NIVOLUMAB PLUS CHEMOTHERAPY FOR ADVANCED GASTRIC, GASTRO-OESOPHAGEAL JUNCTION AND OESOPHAGEAL CANCER
    Young, R.
    Padgett, K.
    Brown, T.
    Okorogheye, G.
    Jones, B.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S119 - S119
  • [10] Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma
    Geh, JI
    Glynne-Jones, R
    Kwok, QSK
    Banerji, U
    Livingstone, JI
    Townsend, ER
    Harrison, RA
    Mitchell, IC
    [J]. CLINICAL ONCOLOGY, 2000, 12 (03) : 182 - 187
12345